Breaking News Instant updates and real-time market news.

BIIB

Biogen

$372.80

14.81 (4.14%)

07:22
07/25/18
07/25
07:22
07/25/18
07:22

Biogen risk/reward positive into Alzheimer's conference, says Canaccord

Canaccord analyst Sumant Kulkarni noted Biogen reported better than expected Q2 results, which were driven by robust Spinraza sales, higher gross margins, and lower R&D expenses. The analyst said the focus is now on the company's BAN2401 presentation at the Alzheimer conference. He said he likes the risk/reward heading into this event. Kulkarni reiterated his Buy rating and $396 price target on Biogen shares.

  • 25

    Jul

  • 25

    Jul

  • 30

    Jul

  • 31

    Jul

BIIB Biogen
$372.80

14.81 (4.14%)

07/23/18
ADAM
07/23/18
NO CHANGE
Target $396
ADAM
Buy
Biogen price target raised to $396 from $335 at Canaccord
Canaccord analyst Sumant Kulkarni raised his price target on Biogen to $396 from $335 as he likes the set-up heading into Q2 earnings, a fuller data release on their Alzheimer's drug, and a subsequent webcast that will highlight the company's high risk/reward Alzheimer's disease pipeline. Kulkarni noted the shares have risen roughly 20% since the preliminary data was released, so he is not ruling out a pullback, but he said if it should occur he recommends buying the weakness. Kulkarni reiterated his Buy rating on Biogen shares.
07/23/18
OPCO
07/23/18
NO CHANGE
Target $400
OPCO
Outperform
Oppenheimer anticipating potential volatility ahead for Biogen
Oppenheimer analyst Jay Olson anticipates Biogen (BIIB) volatility driven by Q2 results along with AD presentations at AAIC that include promising BAN2401 data, which was recently top-lined. The analyst expects a focus on ADCOMS component scores and effect sizes for BAN2401. With regards to Q2 results, Olson expects top-line growth of 4% and non-GAAP EPS of $3.95 which is impacted by the Ionis Pharmaceuticals (IONS) deal upfront payment. Additionally, he expects continued strong Spinraza and biosimilar growth. Olson reiterates an Outperform rating and $400 price target on Biogen's shares.
07/24/18
PIPR
07/24/18
NO CHANGE
Target $400
PIPR
Overweight
Piper raises Biogen target to $400 after BAN2401 'stole the show' from earnings
Piper Jaffray analyst Christopher Raymond raised his price target on Biogen to $400 from $365 after "solid" Q2 results that he said were overshadowed by what "investors are interpreting as highly encouraging commentary" regarding the BAN2401 data that will be presented at tomorrow's AAIC meeting. Given what he sees as the "massive stock re-rating potential" associated with a viable Alzheimer's treatment, he thinks investors should continue to own the stock into tomorrow's BAN2401 data and ahead of full Phase 3 data for aducanumab in 2020. Raymond keeps an Overweight rating on Biogen shares.
07/24/18
JPMS
07/24/18
NO CHANGE
Target $445
JPMS
Overweight
JPMorgan expects 'FOMO' trading for Biogen, ups price target to $445
JPMorgan analyst Cory Kasimov said Biogen's "nice beat-and-raise" report was "an encouraging start" to the Q2 earnings season, adding that its MS franchise remains largely stable. Much of the conference call Q&A focused on Alzheimer's ahead of tomorrow's BAN2401 data presentation and he thought the overall tone of the conversation was "constructive," he tells investors. The analyst, who thinks a significant "fear of missing out" trade may take hold as the highly anticipated aducanumab data readout in early 2020 approaches, raised his price target on Biogen to $445 from $400 and keeps an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

GDDY

GoDaddy

$73.63

0.58 (0.79%)

17:05
07/16/19
07/16
17:05
07/16/19
17:05
Hot Stocks
GoDaddy Chief Accounting Officer Rebecca Morrow resigns »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 14

    Aug

NUS

Nu Skin

$45.50

1.44 (3.27%)

17:05
07/16/19
07/16
17:05
07/16/19
17:05
Hot Stocks
Breaking Hot Stocks news story on Nu Skin »

Nu Skin falls over 14% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUS

Nu Skin

$45.50

1.44 (3.27%)

17:05
07/16/19
07/16
17:05
07/16/19
17:05
Earnings
Nu Skin cuts FY19 EPS view to $3.20-$3.35 from $3.80-$4.05, consensus $3.95 »

Cuts FY19 revenue view to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUS

Nu Skin

$45.50

1.44 (3.27%)

17:03
07/16/19
07/16
17:03
07/16/19
17:03
Earnings
Nu Skin cuts Q2 EPS view to 82c-84c from 91c-98c, consensus 94c »

Cuts Q2 revenue view to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCEHY

Tencent

$0.00

(0.00%)

, ATVI

Activision Blizzard

$46.98

-0.67 (-1.41%)

16:58
07/16/19
07/16
16:58
07/16/19
16:58
Periodicals
Drake's esports team raises $35M, NY Post says »

According to a story from…

TCEHY

Tencent

$0.00

(0.00%)

ATVI

Activision Blizzard

$46.98

-0.67 (-1.41%)

NTES

NetEase

$259.36

3.01 (1.17%)

EA

Electronic Arts

$89.57

-2.65 (-2.87%)

NVDA

Nvidia

$167.06

-0.18 (-0.11%)

AMD

AMD

$33.82

-0.57 (-1.66%)

MSFT

Microsoft

$137.08

-1.86 (-1.34%)

NTDOY

Nintendo

$0.00

(0.00%)

TTWO

Take-Two

$117.49

0.47 (0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 18

    Jul

  • 19

    Jul

  • 30

    Jul

  • 30

    Jul

  • 05

    Aug

  • 06

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 14

    Aug

  • 15

    Aug

  • 05

    Sep

  • 13

    Nov

CSII

Cardiovascular Systems

$44.00

-1.9 (-4.14%)

16:57
07/16/19
07/16
16:57
07/16/19
16:57
Downgrade
Cardiovascular Systems rating change  »

Cardiovascular Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 06

    Aug

  • 09

    Sep

  • 12

    Sep

UAL

United Continental

$94.00

2.7 (2.96%)

16:54
07/16/19
07/16
16:54
07/16/19
16:54
Hot Stocks
Breaking Hot Stocks news story on United Continental »

United Continental sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

UAL

United Continental

$94.00

2.7 (2.96%)

16:53
07/16/19
07/16
16:53
07/16/19
16:53
Hot Stocks
United Continental sees Q3 total mainline aircraft of 804 »

Sees Q3 total regional…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

UAL

United Continental

$94.00

2.7 (2.96%)

16:50
07/16/19
07/16
16:50
07/16/19
16:50
Hot Stocks
United Continental sees FY19 consolidated capacity growth 3%-4% y/y »

Sees FY19: Consolidated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

FARO

Faro Technologies

$46.95

-1.27 (-2.63%)

16:47
07/16/19
07/16
16:47
07/16/19
16:47
Hot Stocks
FARO names Allen Muhich CFO »

FARO announced that Allen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HWC

Hancock Whitney

$38.70

0.28 (0.73%)

16:47
07/16/19
07/16
16:47
07/16/19
16:47
Earnings
Hancock Whitney reports Q2 EPS $1.01, consensus $1.00 »

Reports Q2 NII $219.9M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 23

    Sep

UAL

United Continental

$94.00

2.7 (2.96%)

16:44
07/16/19
07/16
16:44
07/16/19
16:44
Hot Stocks
United Continental sees Q3 capacity growth 2%-3% y/y »

Sees Q3: Adjusted pre-tax…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

16:39
07/16/19
07/16
16:39
07/16/19
16:39
General news
API crude inventories for week of July 12 »

API reports that crude…

HOPE

Hope Bancorp

$13.96

0.2 (1.45%)

16:37
07/16/19
07/16
16:37
07/16/19
16:37
Earnings
Hope Bancorp reports Q2 EPS 34c, consensus 34c »

Net interest income…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

INO

Inovio

$3.00

0.05 (1.69%)

16:35
07/16/19
07/16
16:35
07/16/19
16:35
Hot Stocks
Breaking Hot Stocks news story on Inovio 

Inovio trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMRN

Immuron

$4.27

1.43 (50.35%)

16:32
07/16/19
07/16
16:32
07/16/19
16:32
Syndicate
Immuron files to sell American Depositary Shares, no amount given »

ThinkEquity, a division…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$115.10

1.23 (1.08%)

, GS

Goldman Sachs

$215.57

4.02 (1.90%)

16:32
07/16/19
07/16
16:32
07/16/19
16:32
On The Fly
Fly Intel: Wall Street's top stories for Tuesday »

The major averages were…

JPM

JPMorgan

$115.10

1.23 (1.08%)

GS

Goldman Sachs

$215.57

4.02 (1.90%)

JNJ

Johnson & Johnson

$132.46

-2.21 (-1.64%)

WFC

Wells Fargo

$45.30

-1.4 (-3.00%)

ARW

Arrow Electronics

$67.67

-1.15 (-1.67%)

TSLA

Tesla

$252.38

-1.03 (-0.41%)

APRN

Blue Apron

$10.33

2.68 (35.03%)

BYND

Beyond Meat

$172.50

5.9 (3.54%)

JBHT

J.B. Hunt

$97.76

5.26 (5.69%)

QTT

Qutoutiao

$4.31

-0.22 (-4.86%)

DPZ

Domino's Pizza

$246.55

-23.42 (-8.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 18

    Jul

  • 24

    Jul

  • 29

    Jul

  • 06

    Aug

  • 06

    Aug

  • 06

    Aug

  • 26

    Aug

  • 09

    Sep

  • 16

    Sep

  • 12

    Oct

  • 13

    Nov

PBYI

Puma Biotechnology

$10.78

-0.42 (-3.75%)

16:32
07/16/19
07/16
16:32
07/16/19
16:32
Hot Stocks
Knight says Health Canada approves NERLYNX for early-stage breast cancer »

Knight Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FULT

Fulton Financial

$16.31

0.11 (0.68%)

16:31
07/16/19
07/16
16:31
07/16/19
16:31
Earnings
Fulton Financial reports Q2 EPS 35c, consensus 34c »

Net interest income for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 06

    Aug

  • 07

    Aug

  • 03

    Sep

  • 05

    Sep

WAIR

Wesco Aircraft

$10.84

0.085 (0.79%)

16:30
07/16/19
07/16
16:30
07/16/19
16:30
Hot Stocks
Wesco Aircraft expans business with GKN Aerospace »

Wesco Aircraft Holdings,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
07/16/19
07/16
16:30
07/16/19
16:30
Options
Preliminary option volume of 17.5M today »

Preliminary option volume…

UBNK

United Financial

$14.07

0.05 (0.36%)

16:27
07/16/19
07/16
16:27
07/16/19
16:27
Earnings
United Financial reports Q2 EPS (6c), consensus 24c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

ERYP

Erytech Pharma

$6.69

(0.00%)

16:24
07/16/19
07/16
16:24
07/16/19
16:24
Syndicate
Erytech Pharma files to sell $100M of ADSs »

Representing ordinary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$79.57

1.05 (1.34%)

16:23
07/16/19
07/16
16:23
07/16/19
16:23
Earnings
CSX sees FY19 revenue down 1%-2% vs. prior view of growth »

CSX sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 26

    Aug

  • 13

    Nov

INAP

Internap

$3.56

0.13 (3.79%)

16:22
07/16/19
07/16
16:22
07/16/19
16:22
Hot Stocks
Internap to streamline organization, initiates search for new CFO »

Internap announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.